hormone-guides

Published by Floriva · Updated 2026-05-01 · How Floriva checks its guides

Progesterone and Your Menstrual Cycle

Progesterone rises after ovulation and governs the luteal phase of the menstrual cycle. Understanding what progesterone does in each phase, and what low levels signal, helps you interpret your cycle data.

Progesterone is produced by the corpus luteum after ovulation and is the dominant hormone of the luteal phase. It stabilizes the uterine lining, raises basal body temperature, and produces many of the physical changes associated with the second half of the cycle. Without adequate progesterone, either from anovulation or a weak corpus luteum, cycles shorten, spotting occurs, and the luteal phase cannot sustain its role.

Progesterone is the hormone that defines the second half of the menstrual cycle. It is produced almost exclusively by the corpus luteum, the structure that forms in the ovary after an egg is released. Its rise and fall create the luteal phase, govern uterine lining stability, and produce many of the physical sensations associated with the premenstrual window.

This article is for educational purposes and is not medical advice. Consult a healthcare provider for diagnosis or treatment.

Progesterone by Cycle Phase

Menstrual phase (Days 1 to 5): Progesterone is at its lowest. The corpus luteum from the previous cycle has fully degraded, and the drop in progesterone is what triggered the period. Levels are typically below 1 ng/mL.

Follicular phase (Days 1 to 13): Progesterone remains low throughout this phase. Estrogen is the dominant hormone, driving follicle development and uterine lining growth. Progesterone's role here is minimal. It stays at baseline until ovulation occurs.

Ovulation (around Day 14): The LH surge triggers egg release and transforms the emptied follicle into the corpus luteum. Within 24 to 48 hours of ovulation, progesterone begins rising measurably.

Luteal phase (Days 15 to 28): Progesterone rises steeply, typically peaking around Days 19 to 22 (approximately 5 to 7 days post-ovulation). Peak levels in a healthy cycle range from roughly 10 to 25 ng/mL. This progesterone stabilizes the endometrial lining, raises basal body temperature, modulates the immune system, and slows intestinal transit. If implantation does not occur, the corpus luteum degenerates after about 12 to 14 days, progesterone drops below 2 ng/mL, and menstruation begins.

What Low Progesterone Looks Like in Cycle Data

Low progesterone produces recognizable patterns in tracking data:

Short luteal phase: Fewer than 10 days between confirmed ovulation and the start of the next period. The corpus luteum is not sustaining progesterone production long enough.

Premenstrual spotting: Light bleeding in the days before a full period begins. This suggests progesterone is dropping too early, destabilizing the lining before the full menstrual transition.

No temperature shift: If basal body temperature does not rise after suspected ovulation, progesterone may not have risen, which usually means ovulation did not occur, regardless of other signs.

Heavy or prolonged periods: Without adequate progesterone to organize the endometrial lining during the luteal phase, the lining may be irregularly developed, leading to heavier or prolonged shedding.

Why Ovulation Quality Matters

Progesterone is entirely dependent on ovulation. No ovulation means no corpus luteum means no progesterone. But ovulation is not binary. The quality of the ovulatory event affects how much progesterone the corpus luteum produces.

A follicle that developed under suboptimal conditions, during high stress, caloric restriction, illness, or hormonal disruption, may produce a weaker corpus luteum. This leads to adequate but reduced progesterone: enough for a temperature shift, but perhaps not enough for a full 12 to 14 day luteal phase. The cycle appears regular but the luteal phase is compressed.

This is why cycle tracking that includes ovulation confirmation (BBT, LH testing, or both) provides more actionable information than period tracking alone. The period tells you the cycle ended. Ovulation timing and luteal phase length tell you how the hormonal machinery performed.

What Progesterone Tracking Reveals

Tracking patterns across multiple cycles exposes trends that single-cycle data cannot:

Consistent short luteal phases across many cycles suggest a systemic issue, possibly related to thyroid function, prolactin, or chronic stress, rather than a one-off variation.

Variable ovulation timing with stable luteal length is normal. The follicular phase is variable; the luteal phase is relatively fixed for each individual. If your luteal phase is consistently 12 days, a cycle that ovulates on Day 16 will be 28 days, and one that ovulates on Day 20 will be 32 days. Both are normal.

Worsening luteal patterns over time (progressively shorter luteal phases, increasing premenstrual spotting, or BBT charts showing lower post-ovulatory temperatures) warrant clinical evaluation.

Testing Progesterone

Timing matters for progesterone testing. Progesterone should be tested approximately 7 days after ovulation, not on a fixed cycle day. For a 28-day cycle with Day 14 ovulation, that is Day 21. For a 35-day cycle with Day 21 ovulation, the correct test day is Day 28.

A single progesterone level above 3 ng/mL confirms that ovulation occurred. Levels above 10 ng/mL are generally considered adequate for luteal support. Levels below 10 ng/mL in the mid-luteal phase, combined with short luteal phases or premenstrual spotting, may prompt further evaluation.

Having the Provider Conversation

If your tracking data shows consistent short luteal phases, absent temperature shifts, or premenstrual spotting, bring the data to your provider. Useful framing: "I have been tracking ovulation timing and my luteal phase has been consistently [X] days over the past [Y] cycles. I am also seeing [symptom]. Can we check progesterone at the right time in my cycle?"

The data makes the conversation specific. Instead of "I think something is off," you have measurable patterns that point toward specific tests and diagnoses.